Quest Laboratories share news, announcements and annual reports

NSE: QUESTLABPharmaceuticals & Biotechnology

Quest Laboratories Limited · Face value ₹10 · Listed May 2024 · Issue price ₹97

₹82.00₹2.90 (3.42%)

Share price at the NSE close on 30 Oct 2026. Previous close ₹84.90.

30 Oct: open ₹80.60, high ₹83.90, low ₹80.10

52-week range of traded prices to 30 Oct 2026

₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026

Market cap: ₹134 Cr
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, NSE: 7,20083.3% delivered

Quest Laboratories disputes and clarifications

6 filed, newest first.

Feb 2026
- 9 Feb · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1.Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
Jan 2026
- 13 Jan · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Aug 2025
- 18 Aug · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
Jun 2025
- 24 Jun · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Aug 2024
- 26 Aug · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is enclosed.
Jun 2024
- 28 Jun · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.

Quest Laboratories disputes and clarifications

Feb 2026

Jan 2026

Aug 2025

Jun 2025

Aug 2024

Jun 2024